Results 11 to 20 of about 5,497 (184)

How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?—A prospective study

open access: yesUnited European Gastroenterology Journal, Volume 11, Issue 6, Page 531-541, July 2023., 2023
Abstract Background Timely stratification of Crohn's disease (CD) is essential for patients' management. The use of noninvasive accurate biomarkers is key to monitor treatment and to pursue mucosal healing, the ultimate treatment endpoint in CD. Objective We aimed to evaluate the performance of readily available biomarkers and develop risk matrices to ...
Fernando Magro   +25 more
wiley   +1 more source

COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology

open access: yesUnited European Gastroenterology Journal, Volume 9, Issue 7, Page 750-765, September 2021., 2021
Abstract Background The COVID‐19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health‐related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of
Fernando Magro   +8 more
wiley   +1 more source

The epidemiological profile of patients with inflammatory Bowel disease in the State of Mato Grosso [PDF]

open access: yes, 2008
Recent epidemiological studies suggest that the incidence of Crohn's disease (CD) and Ulcerative Colitis (UC) is increasing in Brazil despite the fact that we do not know what the actual rate is.
Aguilar-Nascimento, José Eduardo de   +2 more
core   +4 more sources

Doença inflamatória intestinal - Doença de Crohn e gravidez: relato de caso Inflammatory bowel disease - Crohn's disease and pregnancy: case report

open access: yesRevista Brasileira de Ginecologia e Obstetrícia, 2011
A Doença de Crohn, uma forma de doença inflamatória intestinal, é frequente em mulheres em idade reprodutiva. Seu acompanhamento requer maior atenção durante a gravidez.
Antônio Braga   +6 more
doaj   +1 more source

Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn's disease from celiac disease Anticorpos anti-Saccharomyces cerevisiae não diferenciam doença de Crohn de doença celíaca

open access: yesArquivos de Gastroenterologia, 2010
CONTEXT: Anti-Saccharomyces cerevisiae antibodies (ASCA), considered serologic markers for Crohn's disease, were described in patients with celiac disease, disappearing after a gluten-free diet.
Lorete Maria da Silva Kotze   +5 more
doaj   +1 more source

Issue Information

open access: yesUnited European Gastroenterology Journal, Volume 11, Issue 6, Page 493-496, July 2023., 2023
No abstract is available for this article.
wiley   +1 more source

Qualidade de vida de pacientes com doença de Crohn

open access: yesEnfermería Global, 2017
Objetivo: Avaliar a qualidade de vida dos pacientes com doença de Crohn atendidos no ambulatório de um Hospital Universitário. Método: Estudo descritivo-exploratório transversal em Hospital Universitário do Piauí- Brasil, de Julho a Dezembro de 2015, e ...
Antonia Mauryane Lopes   +3 more
doaj   +1 more source

The daily impact of COVID‐19 in gastroenterology

open access: yesUnited European Gastroenterology Journal, Volume 8, Issue 5, Page 520-527, June 2020., 2020
A new strain of coronavirus, called SARS‐CoV‐2, emerged in Wuhan, China, in December 2019, probably originating from a wild‐animal contamination. Since then, the situation rapidly evolved from a cluster of patients with pneumonia, to a regional epidemic and now to a pandemic called COrona VIrus Disease 2019 (COVID‐19).
Fernando Magro   +2 more
wiley   +1 more source

Papel da cápsula endoscópica na reclassificação da doença inflamatória intestinal em crianças

open access: yesJornal de Pediatria, 2013
OBJETIVO: Avaliar o papel da cápsula endoscópica na identificação de lesões no intestino delgado em pacientes pediátricos com DII inespecífica (DIII) diagnosticada recentemente e avaliar se os achados da cápsula endoscópica resultam em alterações no ...
Jodie Ouahed   +2 more
doaj   +1 more source

Successful Regulatory T Cell‐Based Therapy Relies on Inhibition of T Cell Effector Function and Enrichment of FOXP3+ Cells in a Humanized Mouse Model of Skin Inflammation

open access: yesJournal of Immunology Research, Volume 2020, Issue 1, 2020., 2020
Background. Recent clinical trials using regulatory T cells (Treg) support the therapeutic potential of Treg‐based therapy in transplantation and autoinflammatory diseases. Despite these clinical successes, the effect of Treg on inflamed tissues, as well as their impact on immune effector function in vivo, is poorly understood.
S. Landman   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy